Antipsychotic drugs for patients with schizophrenia and predominant or prominent negative symptoms: a systematic review and meta-analysis.

Published: 8 Nov 2018 | Version 1 | DOI: 10.17632/59m4njvbrf.1

Description of this data

Data of the following publication:
Krause, Marc; Zhu, Yikang; Huhn, Maximilian; Schneider-Thoma, Johannes; Bighelli, Irene; Nikolakopoulou, Adriani; Leucht, Stefan (2018): Antipsychotic drugs for patients with schizophrenia and predominant or prominent negative symptoms: a systematic review and meta-analysis. In: European archives of psychiatry and clinical neuroscience 268 (7), S. 625–639. DOI: 10.1007/s00406-018-0869-3.

Experiment data files

Latest version

  • Version 1

    2018-11-08

    Published: 2018-11-08

    DOI: 10.17632/59m4njvbrf.1

    Cite this dataset

    Krause, Marc; Zhu, Yikang; Huhn, Maximilian; Bighelli, Irene; Nikolakopoulou, Adriani; Leucht, Stefan (2018), “Antipsychotic drugs for patients with schizophrenia and predominant or prominent negative symptoms: a systematic review and meta-analysis.”, Mendeley Data, v1 http://dx.doi.org/10.17632/59m4njvbrf.1

Categories

Drugs

Mendeley Library

Organise your research assets using Mendeley Library. Add to Mendeley Library

Licence

CC BY 4.0 Learn more

The files associated with this dataset are licensed under a Creative Commons Attribution 4.0 International licence.

What does this mean?

This dataset is licensed under a Creative Commons Attribution 4.0 International licence. What does this mean? You can share, copy and modify this dataset so long as you give appropriate credit, provide a link to the CC BY license, and indicate if changes were made, but you may not do so in a way that suggests the rights holder has endorsed you or your use of the dataset. Note that further permission may be required for any content within the dataset that is identified as belonging to a third party.

Report